REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Societe Adwya Sa (Tunisia)

Main Activities: Medicinal and Botanical Manufacturing
Full name: Societe Adwya Sa Profile Updated: May 17, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

adwya is a pharmaceutical company that operates in Libya, West Africa, and Iraq, developing food supplements and producing medicines under license from major international laboratories, as well as a broad portfolio of branded generics. They aim to be among the top 10 health and well-being laboratories in North Africa by 2030.

Legal Address
Route De La Marsa-Gp 9-Km 14, Bp 658
Tunis Capital; Tunis; Postal Code: 658-2070

Contact Details: Purchase the Societe Adwya Sa report to view the information.

Website: http://www.adwya.com.tn

Basic Information
Total Employees:
Purchase the Societe Adwya Sa report to view the information.
Outstanding Shares:
Purchase the Societe Adwya Sa report to view the information.
Registered Capital:
Purchase the Societe Adwya Sa report to view the information.
Financial Auditors:
Purchase the Societe Adwya Sa report to view the information.
Incorporation Date:
1983
Key Executives
Purchase this report to view the information.
Member of the Management Board
Ownership Details
Purchase this report to view the information.
39.9%
Company Performance
Financial values in the chart are available after Societe Adwya Sa report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TND. Absolute financial data is included in the purchased report.
Net sales revenue
39.35%▲
Total operating revenue
36.38%▲
Operating profit (EBIT)
-324.64%▼
EBITDA
-7.89%▼
Net Profit (Loss) for the Period
-36.45%▼
Total assets
-5.06%▼
Total equity
-3.58%▼
Operating Profit Margin (ROS)
-1.23%▼
Net Profit Margin
0.17%▲
Return on Equity (ROE)
-3.36%▼
Debt to Equity Ratio
11.96%▲
Quick Ratio
0.05%▲
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo